Industry Prospective: The global animal biotechnology market was valued at approximately USD 20.14 billion in 2024 and is projected to reach around USD 58.23 billion by 2034, expanding at a CAGR of roughly 11.20% from 2025 to 2034.
Animal biotechnology is a vital branch of the biotechnology industry, focusing on applying modern molecular biology techniques to genetically modify animals. Its goals include enhancing animal health, productivity, and usefulness across sectors like agriculture, pharmaceuticals, and healthcare. Notable advancements like CRISPR-Cas and Zinc Finger Nucleases are driving new applications and opportunities in this space.
Download Full PDF Sample Copy of Market Report @ https://www.zionmarketresearch.com/sample/animal-biotechnology-market
Estimated CAGR (2025–2034): 11.20%
Market Size in 2024: USD 20.14 Billion
Market Size by 2034: USD 58.23 Billion
Fastest-growing Product Segment: Biologics
Leading End-User Industry: Laboratories
Dominant Region: North America
1. Rising Demand for Animal-Based Products Meat consumption is global, with over 85% of the population consuming poultry, seafood, or other meat. The pharmaceutical industry also heavily relies on animal models for drug and vaccine development.
2. Focus on Animal Welfare Growing concerns over animal health and increasing government funding for animal protection and genetic improvement programs are contributing to market growth.
3. Technological Advancements Cutting-edge genome-editing technologies such as CRISPR-Cas, TALENs, and AI-driven analytics are enabling more precise and efficient research outcomes.
1. Ethical Concerns The practice of genetic modification in animals raises ethical issues and faces opposition from animal rights groups.
2. High Investment Costs Developing biotech facilities and complying with regulatory standards require substantial capital, posing a barrier for new entrants.
1. Innovation in Gene Editing New discoveries in genetics, such as the University of Nebraska's 2024 identification of mutations in cattle, open doors for advanced animal healthcare solutions.
2. Supportive Technologies AI, robotics, and bioreactors are simplifying complex processes and enhancing efficiency in animal biotechnology research.
High cost of setting up large-scale infrastructure.
Strict regulatory frameworks in various countries.
For More Information or Query, Visit @ https://www.zionmarketresearch.com/report/animal-biotechnology-market
By Product:
Nutrition
Drugs
Biologics (32% share in 2024, CAGR 10.01%)
Reproductive & Genetic
Diagnostic
By Application:
Product Research & Development
Preventive Care
Disease Treatment
Veterinary Diagnosis
Others
By End-User Industry:
Veterinary Hospitals & Clinics
Point-of-Care Testing
Laboratories (35% share in 2024)
Others
By Region:
North America (34.01% share in 2024)
Europe
Asia Pacific
Latin America
Middle East & Africa
North America:
Leading region with strong animal welfare programs.
Example: USDA’s $17.6 million investment in agricultural animal welfare in 2024.
Europe:
Increasing demand for biotech-based meat and pet therapies.
Ceva’s 2024 acquisition of Scout Bio showcases expanding market interest.
Phibro Animal Health Corporation
Zoetis Inc.
Elanco Animal Health
Boehringer Ingelheim Animal Health
Bayer Animal Health
Virbac
IDEXX Laboratories
Ceva Santé Animale
Genus plc
Merck Animal Health
Q1. What is animal biotechnology?
Animal biotechnology refers to the use of genetic engineering and molecular biology techniques to improve animal health, productivity, and usefulness across various industries.
Q2. What are the key applications of animal biotechnology?
Applications include drug and vaccine development, disease resistance, enhanced growth, and preventive care in animals.
Q3. Why is North America leading the market?
Due to robust investment in R&D, advanced infrastructure, and supportive animal welfare policies.
Q4. What are the main challenges in this industry?
High operational costs, ethical debates, and strict regulations can hinder growth.
Q5. Which technologies are driving market innovation?
CRISPR-Cas, TALENs, AI-powered tools, robotics, and microfluidic systems.